NSC |
Compound |
Enrichment |
Correlation |
NSC 708421 |
Null |
0.00126165886744893 |
0.13709302 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.00126165886744894 |
0.18011523 |
NSC 176328 |
Ellipticine, 6-(3-aminopropyl)-, dihydrochloride |
0.00126165886744894 |
0.15746184 |
NSC 616960 |
2[5H]-Furanone, 5-[(.beta.-D-glucopyranosyloxy)methyl]-,(S)- (9CI) |
0.00126165886744894 |
0.29182781 |
NSC 618770 |
Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide |
0.00126165886744894 |
0.32325913 |
NSC 625624 |
7,12-Epidioxybenz[a]anthracene, 7,12-dihydro-7-methyl- |
0.00126165886744894 |
0.31174842 |
NSC 736081 |
4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine |
0.00134950525162028 |
-0.03381708 |
NSC 744020 |
methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate |
0.00134950525162028 |
0.048724592 |
NSC 294846 |
Cinnoline, 4-nitro-, 1-oxide |
0.00134950525162029 |
0.27197529 |
NSC 635306 |
Null |
0.00142226725147591 |
0.3901937 |